PPD Inc. Moves Closer to Spinoff of Furiex

| About: Pharmaceutical Product (PPDI)

PPD Inc., a contract research organization (CRO), has filed SEC documents, (specifically a Form 10 Registration Statement), that moves it a step closer to the previously announced stock spin-off of its compound partnering subsidiary, Furiex.

What is a CRO? PPD Inc. (NASDAQ:PPDI) has provided us with a webpage on CROs that has a podcast so that you don’t even have to read.


Furiex is a wholly owned subsidiary of PPD and the plan is that it will be distributed to shareholders of PPDI as a stock dividend. When the spin-off is complete, Furiex will be a completely separate, publicly traded company.

Their present timeline calls for the stock spin-off to occur in mid-2010, though they note in their press release announcing the spin-off that a number of things have to happen in the mean time.

A Triangle Business Journal article notes that PPD Inc. employs about 2,000 people in the Raleigh-Durham area of North Carolina. Hopefully, given the amount of local interest that 2,000 jobs can stir up, we will be getting more information from this source in addition to what is filed with the SEC.

About this article:

Tagged: , Medical Laboratories & Research
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here